Postnatal changes in the activities of acetylcholinesterase and butyrylcholinesterase in rat heart atria

Postnatal development of the activities of acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) in rat heart atria has been investigated with the use of 1.5-bis (allyldimethylammoniumphenyl) pentane-3-dibromide (BW 284 C51) as a selective inhibitor of AChE. Total cholinesterase activity (mumol acetylthiocholine hydrolysed X g-1 per hour) increased from 218 on the 1st day after birth to 426 on the 30th day and diminished to 340 in adult rats. The activity of AChE (mumol acetylthiocholine hydrolysed X g-1 per hour) underwent more dramatic changes, increasing more than 4-fold during the first month of life, from 13 on the 1st to 58 on the 30th day of life and then decreasing to 42 in adult rats. The proportion of AChE on total cholinesterase activity increased from 6% on the 1st day to 12-15% in animals aged 24 days and more. Since AChE is known to be specifically involved in the termination of the action of acetylcholine in the sinoatrial node, the observed postnatal changes in its activity are likely to play a role in the postnatal development of cardiac parasympathetic control.     

Postnatal development of the high-affinity uptake of choline and of the synthesis of acetylcholine in rat heart atria

Isolated heart atria from rats of different ages were incubated in a medium containing (14C)choline and the rates of the uptake of (14C)choline into the tissue and of its conversion to (14C)acetylcholine (ACh) were measured. The synthesis of (14C)ACh (expressed per 1 g of fresh weight) increased from birth until 30 days of age and diminished after 40 days of postnatal life. The rate of (14C)ACh synthesis was considerably diminished when Na+ was omitted from the incubation medium or when hemicholinium-3 was added to it; these effects of the absence of Na+ and of hemicholinium-3 were already manifest on the 1st day after birth, indicating that the sodium-dependent high-affinity uptake of choline is operative and takes part in the synthesis of ACh in the heart from the start of postnatal life (if not earlier). In newborn rats, 4% of the (14C)choline that had been taken up by the atria was converted to (14C)Ach; this proportion rose to 7-9% at the age of 20 and 30 days and in adulthood. The total uptake of (14C)choline expressed per whole atria kept increasing from birth till adulthood when related to the whole atria, but it diminished when related to 1 g of atrial weight.     

Choline acetyltransferase activity in the atria of the rat heart during training bradycardia.

The resting heart rate of rats trained for 19 weeks by swimming fell by 24% and the weight of their atria rose by 22%. Choline acetyltransferase in the atria did not alter significantly, however. In association with other findings, this observation supports the view that the bradycardia of training is not due to increased activity of cholinergic cardioninhibitory nerves.     

Muscarinic cholinoceptors and choline acetyltransferase activity in the hypothalamus of spontaneously hypertensive rats

To study the role of central cholinergic mechanisms in hypertension, we have determined muscarinic receptors using [³H](-)quinuclidinyl benzilate (QNB) and choline acetyltransferase (ChAT) activity in the brain regions of spontaneously hypertensive rats (SHR), stroke-prone SHR (SHRSP) and renal hypertensive rats. The number of muscarinic receptors was significantly (33–38%) elevated in the hypothalamus of SHR and SHRSP at the ages of 16 and 24 weeks compared to that of Wistar-Kyoto rats (WKY). An increased density of muscarinic receptors was consistently observed in the prehypertensive (5 weeks) and developmental (10 weeks) stages of hypertension. In contrast, in the hypothalamus of rats with renal hypertension there was no muscarinic receptor alteration. The receptor alteration in the SHRSP hypothalamus was not abolished by a chronic hypotensive treatment which prevented the development of hypertension, suggesting that an enhancement of the muscarinic receptors in spontaneous hypertension does not occur secondarily to the elevation of blood pressure. The hypothalamus of SHR and SHRSP at the ages of 5 and 24 weeks showed significantly less activity of ChAT. These data demonstrate that there is a specific increase in muscarinic receptors and a decrease in cholinergic activity in the hypothalamus of SHR and SHRSP. Thus, the present study suggests an important role for hypothalamic cholinergic receptors in the pathogenesis of spontaneous hypertension.     

The subcellular distribution of acetylcholine, choline acetyltransferase and cholinesterases in lobster walking leg nerves

—Nerve bundles from the walking legs of the lobster have been homogenized in either isosmotic or hyperosmotic sucrose solutions and subjected to differential and discontinuous density gradient centrifugation. The resulting subcellular fractions were analysed for their concentrations of acetylcholine (ACh), choline acetyltransferase (ChAc) and cholinesterase (ChE). Enzymic characteristics were used for a biochemical identification of the subfractions. Regardless of the osmotic conditions, ACh was always found in the free form; there was no evidence of any‘bound’ester. After ultracentrifugation of homogenates in the hyperosmotic medium a pellet floating atop was formed; it consisted of membrane fragments and contained more than 30 per cent of the choline-esterhydrolysing enzymes, with a 3 to 4-fold increased specific activity. ChAc was found to be increasingly soluble if the ionic concentration was raised to that of the haemolymph body fluid of the lobster. Thus, all the components of the ACh system were present in substantial amounts but the question of their physiological function remains open.     

Evidence for the extreme overestimation of choline acetyltransferase in human sperm, human seminal plasma and rat heart: a case of mistaking carnitine acetyltransferase for choline acetyltransferase

Detection of choline acetyltransferase (ChAc) in a number of non-neuronal tissues has been extremely overestimated. There are two major types of errors encountered. Type 1 error occurs when endogenous substrates (e.g. L-carnitine) are acetylated by acetyltransferase enzymes (e.g. carnitine acetyltransferase ( CarAc ) ) yielding an acetylated product mistaken for acetylcholine (AcCh). In the past, human sperm and human seminal plasma putative ChAc activity has been extremely overestimated due to Type 1 error. This study demonstrates (1) an endogenous acetyltransferase and substrate activity in human sperm and human seminal plasma forming an acetylated product that is not AcCh but probably acetylcarnitine ( AcCar ); (2) that the addition of 5 mM choline substrate does not significantly increase acetyltransferase activity; (3) that boiled seminal plasma contains an endogenous acetyltransferase substrate which is not choline, but probably L-carnitine. Type 2 error occurs when endogenous carnitine acetyltransferase synthesizes true AcCh, resulting in mistaken evidence for ChAc. This is demonstrated by the fact that the choline substrate Km-value for the neuronal or true ChAc from mouse brain is 0.73 +/- 0.06 mM while the Km-value of choline substrate for purified CarAc from pigeon breast muscle is 108 +/- 4 mM. Type 2 error has occurred for the estimation of putative ChAc in rat heart. The rat heart ChAc was measured in previous studies utilizing a concentration of 30 mM choline substrate. While saturation of neuronal ChAc is observed at 2-5 mM choline, saturation of the rat heart CarAc enzyme is not reached until over 800 mM. Purified CarAc significantly synthesizes AcCh at 30 mM choline. Thus, putative ChAc has been greatly overestimated in the scientific literature for mammalian sperm, human seminal plasma and rat heart.     

Acetylcholinesterase and butyrylcholinesterase activity in the atria of the heart of adult albino rats

In experiments on adult albino rats the authors used the substances BW 284 C51 (1.5-bis(allyldimethylammoniumphenyl)-pentane-3-one-dibromide) as a specific inhibitor of acetylcholinesterase (AChE) and ethopropazine (10-(2-diethylaminopropyl) phenothiazine hydrochloride) as a specific inhibitor of butyrylcholinesterase (BuChE) to determine the two enzyme activities in atrial homogenates and to investigate changes after AChE or BuChE inhibition of the negative chronotropic effect of acetylcholine (ACh) on atria incubated in vitro. AChE accounted for only 12% and BuChE for 88% of the total ability of atrial homogenates to hydrolyse acetylcholine. The concentration of exogenous ACh needed to reduce the spontaneous frequency of contractions of the isolated right atrium by 30, 60, or 90/min fell by 78%, 79% and 84% respectively after BW 284 C51 inhibition of AChE and by 95%, 94% and 94% after simultaneous inhibition of AChE and BuChE. The significance of AChE in control of the negative chronotropic effect of ACh is thus evidently significantly greater than would correspond to the percentual proportion of AChE in cholinesterase activities in the atria of the rat heart. In can be assumed that AChE is functionally associated with parasympathetic innervation of the heart and that it is probably present in a high concentration in the primary pacemaker region.     

Regional and subcellular distribution of choline acetyltransferase in the brain of rats

—Homogenates of corpus striatum, cerebral cortex and hypothalamus excised from rat brain were fractionated on discontinuous Ficoll and sucrose density gradients, and the distribution of choline acetyltransferase (ChAc) in the mitochondrial and synaptosomal fractions was determined. In the hypothalamic and cortical regions the fractions enriched in synaptosomes showed much higher activity of ChAc than those containing mainly mitochondria. On the other hand, the corpus striatum showed an equal distribution of ChAc activity in those two fractions. The localization of ChAc was also studied in the postnuclear supernatants obtained from three brain regions, using continuous sucrose density gradients. The distribution of ChAc was compared to that of monoamine oxidase (MAO), potassium and protein. When the pellets obtained from the fractions collected from the gradient were suspended in sucrose, the peak of ChAc activity was close to that of MAO in all three brain regions. When 0.1 mm EDTA +1% butanol was used in order to liberate the occluded form of ChAc, the maximum liberation occurred in lighter fractions, resulting in a shift of the activity peak toward the top of the gradient. This was found with fractions from hypothalamic and cortical regions. In the striatum, the liberated ChAc remained in the same fractions as the occluded enzyme. The results indicate that ChAc is liberated only in those fractions where it is present in synaptosomes. In agreement with the results on the discontinuous gradients this occurs in particles of lower density than mitochondria in cortex and hypo-thalamus, but in particles of similar density to mitochondria in the corpus striatum, indicating regional differences in the distribution of ChAc in the brain. K+ containing particles centrifuged in less dense fractions than those containing ChAc, indicating that synaptosomes are heterogeneous with respect to these two marker substances.     

Developmental changes of choline acetyltransferase (ChAc) activity in chick embryo spinal and sympathetic ganglia

The ChAc activity of spinal and sympathetic ganglia was measured throughout the embryonic life of the chick. In spinal ganglia, the ChAc activity reached a first peak when the maximal proliferation of neuroblasts occurred. Then, the relative ChAc activity decreased. After the 12th day of incubation, the enzyme activity increased again and reached a second peak on the 16th day. In sympathetic ganglia, the general course of the development of ChAc activity was similar to spinal ganglia. However, higher enzymic activity was found. Furthermore, the earlier peak of ChAc activity occurred 48 hr later than the corresponding peak in spinal ganglia. The behaviour of ChAc activity in these two areas of the developing nervous system is interpreted as a function of their histogenesis.